Obiettivo The research project foresees the development of new molecular entities based onmetal-labeled peptides and peptidomimetics able to target with high affinity and selectivity receptor sites overexposed in human tumours. The receptors identified as the most attractive targets for the engineering of novel diagnostic tools are cholecystokinin and foliate. The new molecules will be used as diagnostic probes in nuclear medicine and magnetic resonance imaging depending upon the coordinated metal. The development of prototype contrast agents suitable for clinical diagnosis costumers in humans is the final goal. Campo scientifico natural sciencesbiological sciencesbiochemistrybiomoleculesmedical and health sciencesclinical medicineradiologynuclear medicinemedical and health sciencesclinical medicineoncologyengineering and technologymedical engineeringdiagnostic imagingmagnetic resonance imaging Programma(i) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Argomento(i) 1.1.1.-3. - Key action The "Cell factory" Invito a presentare proposte Data not available Meccanismo di finanziamento EAW - Exploratory awards Coordinatore INBIOS Contributo UE Nessun dato Indirizzo Via A. Olivetti, 1 80078 POZZUOLI Italia Mostra sulla mappa Costo totale Nessun dato Partecipanti (1) Classifica in ordine alfabetico Classifica per Contributo UE Espandi tutto Riduci tutto ISOGEN BIOSCIENCE BV Paesi Bassi Contributo UE Nessun dato Indirizzo Industrieweg 68 3606 AS MAARSSEN Mostra sulla mappa Costo totale Nessun dato
